KRT20 has historically served as a diagnostic marker for colorectal carcinoma [39], whereas high expression of ribosomal protein L32, glutaminase, and DEAD/H box polypeptides has been associated with various cancers and metastatic lesions [40],[41]. This evidence concerns the gene GLS and cancer.